Glytone Clarifying SunVanish with Sunscreen (Genesis Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Glytone Clarifying SunVanish with Sunscreen drug offered from Genesis Pharmaceutical, Inc.. This Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genesis Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Hydroquinone |
| SUBSTANCE NAME: | HYDROQUINONE; OCTINOXATE; OXYBENZONE; AVOBENZONE; OCTOCRYLENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2012-06-13 |
| END MARKETING DATE: | 0000-00-00 |
Glytone Clarifying SunVanish with Sunscreen HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glytone Clarifying SunVanish with Sunscreen from Genesis Pharmaceutical, Inc. |
| LABELER NAME: | Genesis Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40; 75; 50; 20; 18.6(mg/g; mg/g; mg/g; mg/g; mg/g) |
| START MARKETING DATE: | 2012-06-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64760-401_e6fa580b-51ff-4ef9-afbd-caa764539645 |
| PRODUCT NDC: | 64760-401 |
| APPLICATION NUMBER: | |
Other HYDROQUINONE; OCTINOXATE; OXYBENZONE; AVOBENZONE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers:
